期刊文献+

高血压患者血清C-反应蛋白的表达

Expression of C-reactive protein in hypertensive patients
暂未订购
导出
摘要 目的:探讨高血压患者血清C-反应蛋白(CRP)水平变化与预后的关系。方法:40例伴随不同程度动脉硬化的原发性高血压患者分别进行颈动脉粥样硬化检测及血清CRP测定,对测定结果进行统计学分析。结果:40例高血压患者中颈动脉粥样硬化者28例,无颈动脉粥样硬化者12例;同时颈动脉粥样硬化者的血清CRP平均水平明显高于无颈动脉粥样硬化者(t=6.232,P<0.05)。而在颈动脉粥样硬化者中,有颈动脉斑块的患者血清CRP显著高于颈动脉内膜(IMT)增厚患者(t=4.362,P<0.05)。治疗后,所有患者的CRP与治疗前比较均有明显改善,差异有统计学意义(P<0.05)。结论:高血压患者的CRP水平有助于动态评价病情变化和判断临床预后,可作为高血压患者预后不佳发生的重要预测指标,值得临床推广应用。 Objective: To discuss the relaiton of C-reactive protein (CRP) levels and prognosis in hypertensive patients. Methods: 40 patients with different degrees of atherosclerosis with essential hypertension were respectively detected carotid atherosclerosis and serum CRP. Results: Accorded the ultrasound results, 28 cases of carotid artery atherosclerosis and 12 cases without carotid artery atherosclerosis in the 40 cases of hypertension, the former's average level of serum CRP was significantly higher than the latter (t=6.232, P〈0.95). In the carotid atheroselerosis, patients of carotid artery plaque with serum CRP was significantly higher than in patients with thickened IMT (t=4.362, P〈0.05). After treatment, CRP of all patients were significantly improved, the difference was statistically significant (P〈0.05). Conclusion: CRP levels in patients with high blood pressure can help dynamic evaluate of the disease changes and determine the clinical outcome, it can oc- cur as an important prognostic predictor of poor, it is worthy of clinical application.
作者 陈卫钦
出处 《中国医药导报》 CAS 2011年第32期173-174,共2页 China Medical Herald
关键词 高血压 动脉硬化 C反应蛋白 预后 Hypertension Atherosclerosis C-reactive protein Prognosis
  • 相关文献

参考文献10

二级参考文献35

  • 1吴苔,陈莉亚.血清C反应蛋白在新生儿感染时的变化[J].浙江预防医学,2001,13(1). 被引量:19
  • 2洪蕾,冒韵东,杨怀恭.妇科感染中血清C-反应蛋白测定的研究[J].江苏医药,1995,21(1):22-23. 被引量:12
  • 3董解菊,李真,何作云.高敏C-反应蛋白作为冠心病危险因子的临床应用价值[J].国外医学(临床生物化学与检验学分册),2005,26(10):697-699. 被引量:34
  • 4刘彩云,杨蔚,杜红,吴健,孙素莲,寿成超.人血清HER-2/neu胞外域蛋白检测方法的建立[J].中华检验医学杂志,2006,29(4):310-313. 被引量:6
  • 5Horne BD,Muhlestein JB,Carlquist JF,et al.Statin therapy,lipid levels,C-reactive protein and the survival of patients with angiographically severe coronary artery disease.J Am Coll Cardiol,2000,36(6):1774-1780.
  • 6Yu H,Rifai N.High-sensitivity C-reactive protein and atherosclerosis:from theory to therapy.Clin Biochem,2000,33(8):601-610.
  • 7Clarkson P, Celermajer DS, Donald AE,et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels[J]. J Am Coll Cardiol, 1996,28(3):573-579.
  • 8Haverkate F, Thompson SG, Pyke SD,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina[J]. Lancet, 1997,349(9050):462-466.
  • 9Sampietro T,Bigazzi F, Dal-Pino B,et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia a proinflammatory condition[J]?Circulation,2002,105(1):11-14.
  • 10Rajamannan NM, Subramaniam M,Springett M,et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve[J]. Circulation,2002,105(22):2660-2665.

共引文献199

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部